CHILDREN'S

Main information

  • Trade name:
  • CHILDREN'S PANADOL COLD RELIEF ELIXIR bottle
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • CHILDREN'S PANADOL COLD RELIEF ELIXIR bottle
    Australia
  • Language:
  • English

Other information

Status

  • Source:
  • Dept. of Health,Therapeutic Goods Administration - Australia
  • Authorization number:
  • 44006
  • Last update:
  • 01-12-2017

Public Assessment Report

Public Summary

Summary for ARTG Entry:

44006

CHILDREN'S PANADOL COLD RELIEF ELIXIR bottle

ARTG entry for

Medicine Registered

Sponsor

GlaxoSmithKline Consumer Healthcare Australia Pty Ltd

Postal Address

Locked Bag 3,

Ermington, NSW, 2115

Australia

ARTG Start Date

6/05/1993

Product category

Medicine

Status

Active

Approval area

Non-Prescription Medicines

Conditions

Conditions applicable to all therapeutic goods as specified in the document "Standard Conditions Applying to Registered or Listed Therapeutic Goods

Under Section 28 of the Therapeutic Goods Act 1989" effective 1 July 1995.

Conditions applicable to the relevant category and class of therapeutic goods as specified in the document "Standard Conditions Applying to Registered

or Listed Therapeutic Goods Under Section 28 of the Therapeutic Goods Act 1989" effective 1 July 1995.

Products

1. CHILDREN'S PANADOL COLD RELIEF ELIXIR bottle

Product Type

Single Medicine Product

Effective date

4/05/2006

Warnings

No Warnings included on Record

Standard Indications

Specific Indications

Fast effective relief from nasal congestion, runny nose, sneezing, itchy/watery eyes, aches, pains, headaches and fever.

Additional Product information

Container information

Type

Material

Life Time

Temperature

Closure

Conditions

Bottle

Not recorded

4 Years

Store below 30

degrees Celsius

Not recorded

Not recorded

Pack Size/Poison information

Pack Size

Poison Schedule

100mL

(S2) Pharmacy Medicine

200mL

(S2) Pharmacy Medicine

Components

1. Medicine Component

Dosage Form

Oral Liquid

Route of Administration

Oral

Visual Identification

A clear, red semi-viscous liquid.

Active Ingredients

chlorphenamine maleate

.2 mg/mL

Paracetamol

32 mg/mL

Pseudoephedrine hydrochloride

3 mg/mL

© Commonwealth of Australia.This work is copyright.You are not permitted to re-transmit, distribute or commercialise the material without obtaining prior

written approval from the Commonwealth.Further details can be found at http://www.tga.gov.au/about/website-copyright.htm.

Public Summary

Page 1 of

Produced at 01.12.2017 at 09:18:10 AEDT

This is not an ARTG Certificate document.

The onus is on the reader to verify the current accuracy of the information on the document subsequent to the date shown.

Visit www.tga.gov.au for contact information

27-2-2014

Paracetamol use during pregnancy

Paracetamol use during pregnancy

A new Danish study suggests a possible connection between mothers' use of paracetamol painkillers during pregnancy and the risk of developing disorders like ADHD (attention deficit hyperactivity disorder) in children.

Danish Medicines Agency

18-2-2019


Pholcodine / biclotymol / chlorphenamine maleate : List of nationally authorised medicinal products - PSUSA/00010437201804

Pholcodine / biclotymol / chlorphenamine maleate : List of nationally authorised medicinal products - PSUSA/00010437201804

Pholcodine / biclotymol / chlorphenamine maleate : List of nationally authorised medicinal products - PSUSA/00010437201804

Europe - EMA - European Medicines Agency